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The plasma membranes of mononuclear phagocytes contain externally dis-
posed receptors for the Fc portion of immunoglobulin G(IgG) and for the third
component of complement (C3) . Although neither of these receptors has been
isolated, some data are available concerning their physical and functional
properties . The Fc receptors of mouse peritoneal macrophages are resistant to
digestion by trypsin (1), do not require divalent cations for binding IgG-coated
particles (1,2), and mediate both binding and ingestion of these particles (3,4) . In
contrast, the receptors on the macrophage plasma membrane for the third
component of complement are destroyed by tryptic proteolysis (1), require Mg++
ions for binding C3-coated particles (1), and, except under special circumstances
(5,6), mediate binding, but not ingestion, of C3-coated particles to the cell's
plasma membrane (3,5,6) . These findings suggest that the Fe receptors and
complement receptors of mouse peritoneal macrophages are chemically and
physically distinct entities .
In this paper, we identify C3b as the form of C3 responsible for binding
complement-coated erythrocytes to macrophage complement receptors and
demonstrate the functional independence of these receptors from receptors for
the Fc portion ofIgG and from the membrane factors which mediate binding and
ingestion of latex particles .
Materials and Methods
Macrophages .
￿
The methods for harvesting and maintaining mouse peritoneal macrophages were
those of Cohn andBenson (7), as previously modified (8) . Cellswere cultivated for24 h in medium 199
(Microbiological Associates, Bethesda, Md .) with 20% heat-decomplemented (56"C, 30 min) fetal
bovine serum (Grand Island Biological Co ., Grand Island,N.Y .), 100U/ml of penicillin,and 100pg/ml
of streptomycin . In some experiments, mice were injected intraperitoneally with 1 ml of Brewer
thioglycollate medium 4days before their peritoneal macrophageswere harvested . Macrophages from
these animals are designated activated macrophages.
Lvmphocvtes .
￿
Spleens were obtained from mice and teased apart with forceps . The spleen cells
were washed twice in medium 199 and resuspended in medium 199 at a concentration of 2 x 10 6
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cells/ml . More than 95% of the cellswere lymphocytes as judged by morphology and exclusion oflatex
beads . Lymphocytes were not separated from the few contaminating cells .
Erythrocytes . Sheep erythrocytes (E)' in Alsever's solution (Animal Blood Center, Syracuse,
N.Y.) were washed three times inPD [solution "a" of Dulbecco's PBS (9) Jand suspended in medium
199 or Veronal-buffered glucose containing Ca++, Mg++, and gelatin (VBG) (10) .
Complement Source .
￿
Serum was prepared from C5-deficientAKR mice and stored immediately
in 0.2-ml aliquots at -70°C . It served as the source of C1423 . Latex beads, pneumococci, and
antipneumococcal antiserum were obtained and used as previously described (8) .
Rabbit antisheep E IgM (lot no . 30704), at a concentration of 350 Jug/ml, was obtained from
Cordis Laboratories, Miami, Fla. Its hemagglutination titer for E, determined as previously de-
scribed (8), was 1 :320 .
Preparation of Antibody-Coated E.
￿
1ml of 5% (vol/vol) E in medium 199was incubated with 13
ug of rabbit antisheep E IgM for 15 min at 37°C . The suspension was centrifuged for5 min at 750 g,
and the pelleted E were suspended in medium 199 at a concentration of 0.5%. This preparation (0.5%
E coated with anti-E IgM) is designated E(IgM) .
Preparation of Complement-Coated E(IgM) . Freshly thawed AKR mouse serum was diluted
1:10 in VBG and mixed with an equal volume of a suspension of 5% (vol/vol)E(IgM) in VBG. The
mixture was incubated for 10 min at 37°C and centrifuged for 5 min at 750g . The pelleted E were
suspended in medium 199 at a concentration of 0.5%. This preparation [0.5% complement-coated
E(IgM)J is designated E(IgM)C3b .
One volume of 5% E(IgM)C3b in PD (Call- and Mg++-free) was mixed with an equal volume of
freshly thawed AKR mouse serum 50% in PD containing 0.01 M EDTA . The suspension was incu-
bated for 30 min at 37°C. Under these conditions, C3b inactivator in mouse serum cleaves erythro-
cyte-bound C3b to C3c and C3d (11), but activation of the complement cascade cannot occur because
of the absence of divalent cations . The mixturewas centrifuged for5 min at 750 g, and the pelleted E
were suspended in medium 199 at a concentration of0.5%. This preparation [E(IgM)C3b treated with
EDTA-treated AKR mouse serum] is designated E(IgM)C3d. E(IgM)C3d were also prepared by in-
cubating E(IgM)C3b with heat-decomplemented (56°C, 30 min) mouse serum for 30 minat 37°C .
Some E(IgM)C3b were incubated with EDTA-treated AKR mouse serum in the presence of 10
mg/ml of Suramin (IBA Pharmaceuticals, New York, N.Y .), which prevents the cleavage of C3b by
C3b inactivator . VBG, E(IgM), E(IgM)C3b, and E(IgM)C3d were prepared fresh on the day of an
experiment .
Assay of Erythrocyte Rosetting of Lymphocytes .
￿
0.5 ml of a lymphocyte suspension containing
2 x 10 8 cells/ml was mixed with 0.5 ml of a 0.5% suspension of either E(IgM)C3b or E(IgM)C3d in a
test tube, centrifuged for 5 min at 200 g, and incubated for 30 min at 37°C . The cells were resus-
pended by gentle tapping of the tube and rosetting scored by phase-contrast microscopy .
Phase-Contrast and Electron Microscopy .
￿
Cover slip cultures of macrophage monolayers were
fixed with glutaraldehyde and examined by phase-contrast microscopy as previously described (8) .
Cells were processed for electron microscopy as described (12,13) and examined in a Siemens
Elmiskop 1A (Siemens Corp ., Medical/Industrial Groups, Iselin, N.J .) .
Miscellaneous .
￿
Protein determinations were performed by the method of Lowry et al . (14), using
bovine serum albumin as a standard . VBG was prepared as described by Rapp and Borsos (10) .
Results
Interaction of Erythrocyte Preparations with Macrophages . Macrophage
monolayers on glass cover slips were incubated for 30 min at 37°C with a
suspension of E, E(IgM), or E(IgM)C3b . Unattached erythrocytes were removed
by washing, and the preparations were fixed and examined by phase-contrast
' Abbreviations used in this paper : E, sheep erythrocytes ; E(IgM), E coated with anti-E IgM;
E(IgM)C3b, E(IgM) coated with the first four complement components ; E(IgM)C3d, E(IgM)C3b
treated by one of the methods described in Materials and Methods; PBS, phosphate-buffered saline
with Ca" and Mg" ions ; PD, PBS without Ca++ and Mg- ions ; VBG, Veronal-buffered glucose
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and electron microscopy . The results are presented in Table I . Neither E nor
E(IgM) were bound to or ingested by macrophages . E(IgM)C3b avidly attached
to macrophages, in many instances completely covering the cell (Fig . 1) . Very few
E(IgM)C3b were ingested by the macrophages . ThatE(IgM)C3b were only rarely
ingested was confirmed by electron microscopy .
Effect of the Form of Erythrocyte-bound C3 upon the Interaction of Erythro-
cytes with Macrophages . Early in the course of the above experiments, we
noted that incubating E(IgM) with AKR mouse serum for periods longer than
10-15 min resulted in a complement-coated E(IgM) preparation which bound
poorly to the macrophage surface, but which bound well to mouse spleen
lymphocytes . Fig . 2 shows the results of studies in which E(IgM) were incubated
TABLE I
Interaction of Macrophages with Sheep Erythrocytes*
* Each value represents the average of three experiments .
$ Attachment Index is the percentage of macrophages with erythrocytes attached multiplied by the
average number of erythrocytes attached per macrophage times 100 .
§ Phagocytic Index is the percentage of macrophages with erythrocytes ingested multiplied by the
average number of erythrocytes ingested per macrophage times 100 .
FIG. 1 .
￿
Interaction of macrophages with E(IgM)C3b. Phase-contrast microscopy . Macro-
phages were incubated with E(IgM)C3b . Several E(IgM)C3b have bound to the complement
receptors of the macrophage plasma membrane . No erythrocytes have been ingested . x 1,000.
Erythrocyte
preparation
Attachment of
to macrophages
No . per
macrophage
erythrocytes
Index$ %
Phagocytosis of
by macrophages
No . per
macrophage
erythrocytes
Index§
E 0 0 0 0 0 0
E(IgM) 0 0 0 0 0 0
E(IgM)C 81 15 1,215 4 2 81272
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FIG . 2 .
￿
Effect of the time of incubation of E(IgM) with acomplement source (C5-deficient
mouse serum) upon the binding of complement-coated erythrocytes to mouse macrophages
and to mouse lymphocytes . Attachment index is the percentage of macrophages or lympho-
cytes binding erythrocytes multiplied by the average number of erythrocytes bound per cell
times 100 .
with AKR mouse serum at 37'C for periods from 10-60 min, and the resulting
complement-coated erythrocytes were then incubated with either macrophages
or lymphocytes. IgM-coated erythrocytes incubated withAKRmouse serum for
20 min or longer bound maximally to mouse spleen lymphocytes. IgM-coated
erythrocytes incubated withAKRmouse serum for up to 20 min bound avidly to
mouse peritoneal macrophages . However, incubation of these E(IgM)C with
AKR mouse serum for more than 20 min inhibited their capacity to adhere to
mouse macrophages . These findings suggested that, during the longer incubation
periods, serum Cab . inactivator cleaves Cab to C3c and C3d and that the
macrophage complement receptor recognizes only Cab and not Cad . This
hypothesis was supported by the results of experiments presented in Table II .
Incubation ofE(IgM)C3b with either heat-inactivated AKRmouse serum or with
fresh AKRmouse serum containing 0.01M EDTA abolished erythrocyte binding
to macrophages . This effect could be partially prevented by including in the
incubation mixture Suramin, a drug which inhibits the action ofC3b inactivator
(15,16).
All complement-coated E(IgM) preparations remained agglutinable by an
antimouse C3 antibody even after prolonged incubation in mouse serum and
after treatment with heat-inactivated or EDTA-treated mouse serum . Thus, the
treatments with mouse serum did not remove C3 from the erythrocyte surface
but converted C3b to aform of C3 not recognized by the macrophage complement
receptor . Identical results were obtained when activated macrophages were used .
These cells bound and ingested E(IgM)C3b (5,6,17), but failed to interact at all
with E(IgM)C3d (data not shown) . We conclude therefore that the complement
receptor of the plasma membrane of the mouse peritoneal macrophage recognizes
particle-bound C3b but does not recognize particle-bound C3d .
Effect of Ingestion ofLatex Particles or Opsonized Pneumococci upon the Fate
ofE attached to the Macrophage Plasma Membrane via the Cab Receptor .
￿
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TABLE 11
Interaction of Macrophages with Sheep Erythrocytes Coated with C3b or C3d*
+ Suramin, 10 mg/ml
s Griffin, F.M ., J.A . Griffin, J.E . Leider, and S.C . Silverstein . Manuscript in preparation .
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* Each value represents the average of three experiments .
$ E(IgM)C3b prepared by incubation of E(IgM) with freshAKR mouseserum for 10 min at 37°C, as
described in Materials and Methods.
§ As in Table 1 .
though Cab receptors of nonactivated mouse peritoneal macrophages mediate
binding but not ingestion of C3b-coated erythrocytes, C3breceptorsof thioglycol-
late-activated macrophages mediate ingestion of E(IgM)C3b (5,6,17) . Thus,
under some circumstances, the C3 receptor mediates ingestion of C3-coated
erythrocytes . These findings prompted us to test whether a phagocytic stimulus
initiated by another particle via a different membrane receptor would trigger the
ingestion of erythrocytes bound to Cab receptors of nonactivated macrophages.
For this purpose, we used latex particles, which are phagocytized via an as yet
uncharacterized membrane receptor, and opsonized encapsulated pneumococci,
which are ingested via the Fc receptor .
E(IgM)C3b were attached to macrophages; the monolayers were washed to
remove unattached erythrocytes and then incubated for 30 min at 37°C with
1-2 x 10$ latex particles or opsonized pneumococci . These preparations were
then washed, fixed, and examined by phase-contrast microscopy. More than 80%
of macrophages had E(IgM)C3b bound to their plasma membranes and had
ingested 10-20 latex particles (Table III, line 2) or opsonized pneumococci (Table
III, line 3) each . Ingestion of attached E(IgM)C3b was not prompted by
phagocytosis of either latex particles or opsonizedpneumococci (Fig . 3) . That the
erythrocytes remained bound to the macrophage surface was confirmed by
electron microscopy . Addition of anti-C3 IgG to E(IgM)C3b attached to
macrophages promotes ingestion of these erythrocytesz; thus, binding via Cab
receptors does not constitute an impediment to the ingestion of the bound
erythroytes . These results provide additional evidence that the various
phagocytic receptors function independently of each other and indicate that a
signal initiating ingestion via one type of receptor is not transmitted to other
potentially phagocytic receptor sites.
Attachment of erythrocytes
Pretreatment of
E(IgM)C3bf for
Presumed form
ofC3 on
to macrophages
30 min at 37°C E(IgM) No . per %
Index§
macrophage
Veronal-buffered glucose C3b 97 13.4 1,300
Heat-decomplemented C3d 28 2.1 59
AKR mouseserum
AKRmouseserum + 0.01MEDTA C3d 33 2.3 76
AKR mouseserum + 0.01MEDTA C3band C3d 87 5.2 4521274 CHARACTERIZATION OF MACROPHAGE COMPLEMENT RECEPTOR
TABLE III
Fate of Macrophage-Bound E(IgM)C3b During Ingestion of Latex and Pneumococci by
Macrophages*
Attachment of E(IgM)C3b Phagocytosis ofE(IgM)C3b
to macrophages
￿
by macrophages
Particle
* Each value represents the average of three experiments .
$ As in Table I .
§As in Table I .
No . of latex
particles or
FIG. 3 Failure of test particle ingestion to promote phagocytosis of membrane-bound
E(IgM)C3b . Phase-contrast microscopy . E(IgM)C3b were attached to macrophagesas in Fig.
1 . The macrophages were then incubated with opsonized pneumococci. Pneumococci have
been ingested, while erythrocytes remain bound to the complement receptors of the
macrophage plasma membrane . Identical resultswere obtained when latex particleswere used
as test particles . x 1,000 .
Discussion
The complement receptors of guinea pig polymorphonuclear leukocytes (18),
human monocytes (19), human polymorphonuclear leukocytes (20), and acti-
vated mouse peritoneal macrophages (5,6,17) mediate particle ingestion . It has
been reported previously (3,5) that the complement receptor of the mouse
peritoneal macrophage mediates binding of E(IgM)C to the cell surface but
prompts little, if any, ingestion of E(IgM)C . The data reported in Table I also
added
%
No . per
macro-
phage
Index$ %
No . per
macro-
phage
Index§
opsonized pneumo-
cocciingested
permacrophage
None 81 15 1,215 4 2 8 -
Latex 80 14 1,120 4 2 8 10-20
Opsonized 77 15 1,155 2 2 4 10-20
pneumococciFRANK M. GRIFFIN, CELSO BIANCO, AND SAMUEL C. SILVERSTEIN
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show that the complement receptor of mouse macrophages does not mediate
ingestion of complement-coated erythrocytes. Thus, the nonactivated mouse
peritoneal macrophage differs from many phagocytes in that its complement
receptor mediates only binding of particles to the cell's surface.
Cab inactivator (KAF, conglutinogen activating factor) is a heat stable enzyme
present in normal serum which cleaves particle-bound C3b into a C3c fragment
which is released into the fluid phase and a Cad fragment which remains bound
to the particle (reviewed in 11). Many leukocytes bear receptors for C3, and the
interaction of antigen-antibody complexes with one or another form of C3 has
physiological importance in determining the fate of these complexes. Polymor-
phonuclear leukocytes have receptors for only Cab (18,21). Blymphocytes, on the
other hand, have receptors for both C3b and Cad-bearing erythrocytes (21,22).
Little information is available concerning the forms of C3 mediating particle
attachment to macrophages. Reynolds et al . (23) reported that rabbit and human
alveolar macrophages have receptors for C3b but not for C3d.
We have shown that the complement receptor of the mouse peritoneal
macrophage does not recognize allforms of erythrocyte-bound C3. When E(IgM)
were incubated with C5-deficient mouse serum for 10 min, the resulting
complement-coated E(IgM) bound avidly to both mouse macrophages and
mouse lymphocytes. When the time of incubation of E(IgM) with serum was
prolonged, however, binding of these particles to macrophages was markedly
reduced, while their binding to lymphocytes was unaltered. The component of
mouse serum which abolishes the binding of complement-coated E(IgM) to
macrophages is heat stable and does not require divalent cations for its action,
properties which are identical to those of Cab inactivator of rabbit, guinea pig,
and human serum. Suramin, a drug which inhibits the action of Cab inactivator
(15,16), partially prevents the serum-mediated inhibition of binding of comple-
ment-coated E(IgM) to macrophages. None of these treatments of complement-
coated E(IgM) removes C3 from the erythrocyte surface, for the erythrocytes can
be agglutinated by an anti-C3 antiserum. All of these results strongly suggest
that the mouse macrophage complement receptors recognize particle-bound Cab
but do not recognize particle-bound C3d, and in that regard are similar to the
complement receptors of human and rabbit alveolar macrophages (23) .
In a previous study (8), we bound mouse erythrocytes to mouse peritoneal
macrophages using F(ab') 2 immunoglobulin links. When these macrophages with
erythrocytes bound to their plasma membranes were fed either latex particles or
opsonized pneumococci, the latex paritcles and opsonized pneumococci were
ingested, but the erythrocytes remained bound to the macrophage plasma
membrane. We concluded from these studies that the stimulus to ingest one
particle does not trigger the generalized ingestion of other particles attached to
the cell's plasma membrane and that the phagocytic stimulus is confined to that
segment of the cell's plasma membrane immediately adjacent to the particle
being ingested.
Erythrocytes bound to macrophages by the C3b receptor provide better
membrane markers than those bound by F(ab') s immunoglobulin fragments for
several reasons. First, the binding is more stable; attached E(IgM)C3b are not so
easily washed off the macrophage surface as the immunologically attached1276
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erythrocytes . Second, the complement receptor is a single functional entity,
whereas the sites on the macrophage plasma membrane which bind the F(ab') 2
reagent used previously have not been characterized and are probably quite
heterogeneous . Finally, the complement receptor is a membrane structure the
function of which closely resembles that of the Fc receptor ; in thioglycollate-
activated mouse peritoneal macrophages, both the complement and Fc receptors
mediate phagocytosis . Thus, our demonstration that ingestion mediated by
either the Fc receptor (opsonized pneumococci) or a nonspecific phagocytic
receptor (latex particles) fails to initiate phagocytosis of particles bound to the
C3b receptor provides additional evidence that the various phagocytic receptors
function independently of each other and indicates that a signal initiating
ingestion via one type of receptor is not transmitted to all receptors which have
the potential to mediate phagocytosis
Summary
The complement receptor of the macrophage plasma membrane recognizes
particle-bound C3b butdoes notrecognize particle-bound Cad . C3b-coated sheep
erythrocytes were bound to macrophages via their Cab receptors, and the
preparations were then incubated with either latex particles or opsonized
pneumococci (test . particles) . Macrophages ingested the test particles, but
erythrocytes were not ingested ; they remained bound to C3b receptors of the
macrophage plasma membrane . Thus, a signal initiating ingestion via one type of
receptor is not transmitted to all receptors which have the potential to mediate
phagocytosis .
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